Company profile TARA
After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0. Protara Therapeutics expected interest is significantly lower compared to previous quarter (-100.0%) but similar to same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 84 | 51 -39.3% QoQ | 50 -2.0% QoQ | 21 -58.0% QoQ |
| 2020 | 80 -4.8% YoY 281.0% QoQ | 107 109.8% YoY 33.8% QoQ | 74 48.0% YoY -30.8% QoQ | 224 966.7% YoY 202.7% QoQ |
| 2021 | 101 26.2% YoY -54.9% QoQ | 108 0.9% YoY 6.9% QoQ | 124 67.6% YoY 14.8% QoQ | 159 -29.0% YoY 28.2% QoQ |
| 2022 | 171 69.3% YoY 7.5% QoQ | 114 5.6% YoY -33.3% QoQ | 103 -16.9% YoY -9.6% QoQ | 73 -54.1% YoY -29.1% QoQ |
| 2023 | 0 -100.0% YoY -100.0% QoQ | 121 6.1% YoY inf% QoQ | 194 88.3% YoY 60.3% QoQ | 45 -38.4% YoY -76.8% QoQ |
| 2024 | 0 -38.4% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of Protara Therapeutics was 7.68 per week. The last year interest of Protara Therapeutics compared to the last 5 years has changed by -9.9%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 49.46%.
There is not enough data for lymphatic malformations treatment to provide analysis
There is not enough data for lymphatic malformations treatment to provide correlation calculation
There is not enough data for lymphatic malformations treatment to provide analysis
There is not enough data for TARA-002 cell therapy to provide analysis
There is not enough data for TARA-002 cell therapy to provide correlation calculation
There is not enough data for TARA-002 cell therapy to provide analysis
After 39 days of this quarter the interest is at 138.0. Based on that we can calculate that during remaining 52 days it will total up to 322.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 133 | 247 85.7% QoQ | 368 49.0% QoQ | 232 -37.0% QoQ |
| 2020 | 231 73.7% YoY -0.4% QoQ | 204 -17.4% YoY -11.7% QoQ | 225 -38.9% YoY 10.3% QoQ | 180 -22.4% YoY -20.0% QoQ |
| 2021 | 238 3.0% YoY 32.2% QoQ | 143 -29.9% YoY -39.9% QoQ | 143 -36.4% YoY 0.0% QoQ | 238 32.2% YoY 66.4% QoQ |
| 2022 | 304 27.7% YoY 27.7% QoQ | 271 89.5% YoY -10.9% QoQ | 344 140.6% YoY 26.9% QoQ | 230 -3.4% YoY -33.1% QoQ |
| 2023 | 267 -12.2% YoY 16.1% QoQ | 350 29.2% YoY 31.1% QoQ | 195 -43.3% YoY -44.3% QoQ | 362 57.4% YoY 85.6% QoQ |
| 2024 | 138 -48.3% YoY -61.9% QoQ | - | - | - |
The average 5 years interest of rare disease treatment was 19.32 per week. The last year interest of rare disease treatment compared to the last 5 years has changed by 22.31%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by 6.39%.
There is not enough data for intravenous choline chloride to provide analysis
There is not enough data for intravenous choline chloride to provide correlation calculation
There is not enough data for intravenous choline chloride to provide analysis
There is not enough data for intestinal failure associated liver disease to provide analysis
There is not enough data for intestinal failure associated liver disease to provide correlation calculation
There is not enough data for intestinal failure associated liver disease to provide analysis
After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0. ArTara Therapeutics expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 56 | 70 25.0% QoQ | 89 27.1% QoQ | 112 25.8% QoQ |
| 2020 | 72 28.6% YoY -35.7% QoQ | 62 -11.4% YoY -13.9% QoQ | 40 -55.1% YoY -35.5% QoQ | 134 19.6% YoY 235.0% QoQ |
| 2021 | 35 -51.4% YoY -73.9% QoQ | 19 -69.4% YoY -45.7% QoQ | 60 50.0% YoY 215.8% QoQ | 135 0.7% YoY 125.0% QoQ |
| 2022 | 67 91.4% YoY -50.4% QoQ | 83 336.8% YoY 23.9% QoQ | 71 18.3% YoY -14.5% QoQ | 72 -46.7% YoY 1.4% QoQ |
| 2023 | 71 6.0% YoY -1.4% QoQ | 57 -31.3% YoY -19.7% QoQ | 207 191.5% YoY 263.2% QoQ | 85 18.1% YoY -58.9% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of ArTara Therapeutics was 6.12 per week. The last year interest of ArTara Therapeutics compared to the last 5 years has changed by 22.88%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by 6.82%.
There is not enough data for Protara Therapeutics headquarters to provide analysis
There is not enough data for Protara Therapeutics headquarters to provide correlation calculation
There is not enough data for Protara Therapeutics headquarters to provide analysis
After 39 days of this quarter the interest is at 50.0. Based on that we can calculate that during remaining 52 days it will total up to 117.0. Protara Therapeutics stock expected interest is significantly higher compared to same quarter last year (+46.2%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 17 | 106 523.5% QoQ | 143 34.9% QoQ | 68 -52.4% QoQ |
| 2020 | 29 70.6% YoY -57.4% QoQ | 22 -79.2% YoY -24.1% QoQ | 127 -11.2% YoY 477.3% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2021 | 98 237.9% YoY inf% QoQ | 175 695.5% YoY 78.6% QoQ | 85 -33.1% YoY -51.4% QoQ | 104 inf% YoY 22.4% QoQ |
| 2022 | 109 11.2% YoY 4.8% QoQ | 124 -29.1% YoY 13.8% QoQ | 51 -40.0% YoY -58.9% QoQ | 51 -51.0% YoY 0.0% QoQ |
| 2023 | 80 -26.6% YoY 56.9% QoQ | 175 41.1% YoY 118.8% QoQ | 52 2.0% YoY -70.3% QoQ | 112 119.6% YoY 115.4% QoQ |
| 2024 | 50 -37.5% YoY -55.4% QoQ | - | - | - |
The average 5 years interest of Protara Therapeutics stock was 6.81 per week. The last year interest of Protara Therapeutics stock compared to the last 5 years has changed by 17.47%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 19.23%.